MORPHINE SULFATE INJECTION

The Defense Logistics Agency awarded a single-line-item delivery order under contract SPE2DX25D9900 to DMS PHARMACEUTICAL GROUP INC, with CAGE code 1UNB0, for the supply of one package of MORPHINE SULFATE INJECTION (NSN 6505014830274, NDC 00641-6127-25) at a fixed price of $42.99. The award, issued on July 15, 2026, is a delivery order with the unique identifier SPE2DP26F7716 and requires delivery to the USNS OSCAR V. PETERSON at FPO AE 09592 on or before the same date. The contract specifies FOB destination terms, meaning the contractor bears all costs and risks until the item is received at the destination, where government personnel will inspect and accept the goods. Shipment must occur via the fastest traceable means, explicitly excluding parcel post, and all packaging and documentation must be marked with the designated identification numbers in block letters. The contractor, certified as a Women-Owned Small Business and a small business, is subject to compliance with SAM and FAR 19.15 requirements. Payment will be processed by the Defense Finance and Accounting Service in Columbus, Ohio, using the accounting code 97X4930 5CBX 001 2620 S33189 and agency code 97AS. No option periods, quantity variances, or substitution allowances are permitted beyond the exact item specified, and no alternate packaging, preservation, or marking standards are defined beyond the traceability and labeling instructions. Contract administration is handled by DLA Troop Support in Philadelphia, with Lisa Quinn as the contracting officer and Shairy M. Cartagena as the local administrator; no named COR or COTR is assigned. The procurement likely followed an LPTA methodology given the fixed-price, one-time delivery of a standard pharmaceutical with no documented technical evaluation criteria. Electronic invoicing is expected through DLA’s standardized systems, and vendor compliance with the Vendor Shipping Module is required.